As previously demonstrated by our group, myeloid leukemia cells can provide direct costimulation via CD80, CD86, and ICOS-LG molecules, and these malignant blasts are proficient in utilizing elaborate immune evasion strategies including the adaptive resistance and T-cell exhaustion2,4,5,40. This evidence concerns the gene CD86 and myeloid leukemia.